What Happened?
Rockville, MD-based Regenxbio Promoted Curran Simpson as Chief Operating Officer
Date of management change: January 09, 2023
Rockville, MD-based Regenxbio Promoted Curran Simpson as Chief Operating Officer
Regenxbio is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. Regenxbio`s NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. Regenxbio`s mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on Regenxbio`s NAV Technology Platform. Regenxbio seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees.
Curran Simpson is Chief Operating Officer at Regenxbio. Previously, Curran held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Ressler Andrew, Kendall Jeffrey, Brunt Guy, Thiede Andy, Johnson Bob, Huynh David, Myhre Robert, Reardon Arthur, Kothary Jayna, Briggs Darren, Rivers John
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.